Abstract: A turbine engine rotor component, such as a compressor or turbine disk or seal element, is protected from corrosion by depositing an aluminum or chromium coating on the component. The deposition can be performed by a vapor deposition process, such as metal organic chemical vapor deposition (MOCVD), to a coating thickness of from about 0.2 to about 50 microns, typically from about 0.5 to about 3 microns. In one embodiment, the method is conducted in a vapor coating container having a hollow interior coating chamber, and includes the steps of loading the coating chamber with the component to be coated; and flowing a tri-alkyl aluminum or chromium carbonyl coating gas into the loaded coating chamber at a specified temperature, pressure, and time to deposit an aluminum or chromium coating on the surface of the component. The coated component is then heated in a nonoxidizing atmosphere to a specified temperature to form an aluminide or chromide coating on the surface.

Abstract: Disclosed herein are compositions useful for introducing metal carboxylate salts as catalysts into systems useful for producing polyurethane and polyisocyanurate foams. The methods permit the introduction of such catalysts in the absence of substantial amounts of water which otherwise cause inferior foams to be produced. A method for producing foam employing the catalysts are also described.

Abstract: This invention concerns a process for the manufacture of a press molded material, comprising applying diisocyanate, polyol, and catalyst to a wood material, wherein the catalyst is a tertiary amine-carboxylic acid salt that is blocked at room temperature and becomes unblocked at an elevated temperature, and heating the resulting mixture to a temperature effective to unblock the salt to produce unblocked tertiary amine. The press molded material can be an orientated strand board (OSB).

Abstract: This invention concerns a compound formed from a tertiary amine-carboxylic acid salt, where the carboxylic acid and tertiary amine are selected such that the catalyst salt is blocked at room temperature and becomes unblocked at an elevated temperature. The compound is useful as a heat activated urethane catalyst.

Abstract: This invention generally relates to a method and apparatus for determining carbon emission reduction credits and, more particularly, to a method and apparatus for generating and quantifying standardized carbon emission reduction credits. General data and site-specific data, if available, are input into a carbon sequestration model to determine the approximate change in the level of carbon compounds stored in a media, such as soil, over a specified period of time. An uncertainty analysis is conducted on the results to quantify and normalize carbon emission reduction credits. Standardized carbon emission reduction credits may be compiled for trade and other carbon emission reduction credits are placed in reserve.

Abstract: The present application relates to a method for enhancing the therapeutic index of a compound that is useful to treat tumors. More specifically, the present invention relates to a method for administering IL-2 to a tumor patient to maximize the therapeutic efficacy and minimize the toxicity.

Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.

Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using a colony stimulating factor in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, and damage caused by radiation therapy, high oxygen tension, and chemotherapy.

Abstract: A seed drill includes a novel planting assembly combining press wheels for packing angular sides of a furrow and a runner immediately behind and longitudinally aligned with the press wheel. The runner includes an arcuate front edge that is juxtaposed immediately behind the coulter, thereby preventing accumulation of field trash between them. The runner extends rearwardly from beneath the press wheel and is transversely guided on the supporting vehicle frame of the drill to maintain it in longitudinal alignment within an open longitudinal slot cut through the soil and intersecting the base of the packed furrow. Seed is dropped into the open slot prior to being covered with soil. Moist soil can be packed along the sides of the furrow to maintain the furrow in an open condition during seed germination and plant emergence. Highly accurate planting depth control can be achieved, with provision for upward relative movement of the runner as required by encountered field conditions.

Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using a tumor necrosis factor in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, and damage caused by radiation therapy, high oxygen tension, and chemotherapy.

Abstract: A seed drill includes a novel planting assembly combining press wheels for packing angular sides of a furrow and a runner immediately behind and longitudinally aligned with the press wheel. The runner extends rearwardly from beneath the press wheel at the lower end of an arcuate shank that is transversely guided on the press wheel structure or frame of the drill to maintain it in longitudinal alignment within an open longitudinal slot cut through the soil and intersecting the base of the packed furrow. The shank is guided by a series of rollers within a guide frame pivotally mounted on a supporting frame for motion about a transverse horizontal axis. Highly accurate planting depth control can be achieved, with provision for upward relative movement of the runner as required by encountered field conditions.

Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using a lymphokine or cytotoxin in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, and damage caused by radiation therapy, high oxygen tension, and chemotherapy.

Abstract: A seed drill includes a novel planting assembly combining press wheels for packing angular sides of a furrow and a runner immediately behind and longitudinally aligned with the press wheel. The runner extends rearwardly from beneath the press wheel and is transversely guided on the press wheel structure or frame of the drill to maintain it in longitudinal alignment within an open longitudinal slot cut through the soil and intersecting the base of the packed furrow. Seed is dropped into the open slot prior to being covered with soil. Moist soil can be packed along the sides of the furrow to maintain the furrow in an open condition during seed germination and plant emergence. Highly accurate planting depth control can be achieved, with provision for upward relative movement of the runner as required by encountered field conditions.

Abstract: Anti-tumor activity in mammals can be augmented by administering to the mammalian host a synergistically effective amount of TNF and IL-2 or of TNF and IFN-.beta., or of TNF, IL-2 and IFN-.beta. in combination. The composition of TNF and IL-2 and/or IFN-.beta. may be prepared in vitro or administered separately to the host. If the TNF and IL-2 are administered sequentially, the TNF must be administered prior to the IL-2 to obtain synergy. The composition is useful for treating such cancers as mastocytoma, melanoma, leukemia, lymphoma, mammary adenocarcinoma, and pharyngeal squamous cell carcinoma.

Abstract: A seed drill includes a novel planting assembly combining press wheels for packing angular sides of a furrow and a runner immediately behind and longitudinally aligned with the press wheel. The runner extends rearwardly from beneath the press wheel and is transversely guided on the press wheel structure to maintain it in longitudinal alignment within an open longitudinal slot cut through the soil and intersecting the base of the packed furrow. Seed is dropped into the open slot prior to being covered with soil. Moist soil can be packed along the sides of the furrow to maintain the furrow in an open condition during seed germination and plant emergence. Highly accurate planting depth control can be achieved, with provision for upward relative movement of the runner as required by encountered field conditions.

Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.

Abstract: Anti-tumor activity in mammals can be augmented by administering to the mammalian host a synergistically effective amount of TNF and IL-2 or of TNF and IFN-.beta., or of TNF, IL-2 and IFN-.beta. in combination. The composition of TNF and IL-2 and/or IFN-.beta. may be prepared in vitro or administered separately to the host. If the TNF and IL-2 are administered sequentially, the TNF must be administered prior to the IL-2 to obtain synergy. The composition is useful for treating such cancers as mastocytoma, melanoma, leukemia, lymphoma, mammary adenocarcinoma, and pharyngeal squamous cell carcinoma.

Abstract: An auxiliary support for permitting longitudinal travel of transversely elongated agricultural implements comprises a pivoted lifting frame adapted to extend outwardly and downwardly to elevationally raise the implement framework at one side. The outer end of the lifting frame is provided with a wheel aligned in the desired longitudinal direction of travel. An adjustable and removable saddle has an extension that overlies the implement frame to permit interposition of a conventional jack to raise and lower the implement framework as required. The elevated implement framework is held in a travel position by chains extending between the outer end of the lifting frame and brackets attached to the implement framework. A foldable hitch frame can be provided at one side of the implement framework to facilitate towing of the implement in a direction perpendicular to its normal direction of field movement.

Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using a lymphokine or cytotoxin in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The lymphokine or cytotoxin is preferably tumor necrosis factor and the biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, and damage caused by radiation therapy, high oxygen tension, and chemotherapy.

Abstract: Tumor necrosis factor and a suitable immuotoxin when administered simultaneously or in tandem produce a synergistic effect in treating tumor burden in warm-blooded animals. Methods and protocols for obtaining this syneristic effect are disclosed, as well as compositions effective in this treatment.